Getting Started with Mounjaro: How Many Doses in One Mounjaro Pen?

Last reviewed: July 18, 2026

Last updated: July 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Mounjaro pens revolutionized GLP-1 therapy by providing a convenient pre-filled delivery system, with each pen holding exactly four weekly doses that progress through a standard titration schedule. Understanding how these pens work helps patients manage their treatment timeline and refill schedule effectively. PlexusDx compounded tirzepatide injections follow the same dosing framework while offering flexibility and affordability without the brand-name markup.

How Many Weekly Doses Are in a Mounjaro Pen?

Each Mounjaro pen contains four pre-filled, single-dose injection pens—one for each week of a standard four-week treatment cycle. The standard initiation protocol begins at the lowest dose (2.5 mg) in week one, then escalates to 5 mg in week two, 7.5 mg in week three, and 10 mg in week four. This gradual increase, called dose titration, allows the body to adapt to the medication while minimizing gastrointestinal side effects that can occur with rapid escalation.

Once a patient completes the initial four-week cycle, they either continue at the highest dose or may escalate further depending on clinical response and tolerance. The pen design makes this schedule straightforward—patients inject once weekly on the same day, then move to the next pre-filled pen the following week. This architecture eliminates confusion about dose calculation and reduces the risk of administration errors compared to multi-dose vials.

Why Tirzepatide Uses a Four-Week Dosing Schedule

Tirzepatide, the active compound in Mounjaro, belongs to a dual-mechanism class called GIP/GLP-1 receptor agonists, which stimulate two distinct appetite and metabolic pathways in the brain and pancreas simultaneously. Clinical trials demonstrated that the four-week titration schedule optimizes tolerability by allowing the body's receptors to gradually acclimate to dual activation, reducing nausea and other adaptation-related side effects. A slower initiation typically results in better long-term adherence because patients experience fewer early discontinuations due to GI discomfort.

The weekly injection frequency (every seven days) maintains steady plasma concentrations of tirzepatide, which has a half-life of approximately five days. This consistent exposure supports sustained appetite suppression and improved blood sugar control throughout the week. Unlike daily oral medications, the once-weekly injection format improves adherence rates and reduces the likelihood of missed doses.

Compounded Tirzepatide vs. Brand-Name Mounjaro Pens

PlexusDx compounded tirzepatide injections contain the same active pharmaceutical ingredient (tirzepatide) as Mounjaro but are prepared by licensed 503A compounding pharmacies rather than manufactured as brand-name medications. The clinical efficacy and safety profile remain equivalent because the tirzepatide molecule itself is identical. The key difference lies in cost—PlexusDx tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan flat, regardless of dose tier, whereas brand-name Mounjaro lists at about $1,090 monthly as of August 2026 before any savings-card or self-pay option.

Compounded versions offer additional flexibility in dosing schedules and customization options that some patients find beneficial. PlexusDx patients receive their tirzepatide injections from licensed compounding pharmacies and can progress through titration at their own pace without being locked into specific pen configurations. All 50 states are served, no insurance is required, and doses are HSA/FSA eligible—features that dramatically simplify access for patients without employer coverage or those seeking direct-pay options.

Managing Your Tirzepatide Treatment Timeline and Refills

Once a patient completes the initial four-week titration cycle with four doses from one pen, the next refill depends on their maintenance strategy. Some patients remain on 10 mg weekly indefinitely, while others may escalate further (up to 15 mg) if they continue to show benefit and maintain good tolerability. Tracking refill dates is straightforward: if starting on a Monday, subsequent refills arrive every 28 days, ensuring continuous access without gaps in treatment.

The PlexusDx Precision Peptide Genetic Test ($298) analyzes GIPR, FTO, and MC4R — variants that relate to GLP-1 and related signaling pathways. It does not predict your response to tirzepatide or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437 , FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection is $289/mo month-to-month, or from $249/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Do I need a new Mounjaro pen every week, or does one pen last the whole month?

One Mounjaro pen contains four pre-filled doses—one for each week of the first month. After four weeks, you'll need a new pen (or refill) if continuing treatment. PlexusDx compounded tirzepatide follows the same weekly dosing schedule, with refills coordinated monthly based on your injection day.

What happens if I miss a weekly tirzepatide injection?

If you miss a scheduled dose, take it as soon as you remember unless your next dose is due within two days; in that case, skip the missed dose and resume your normal schedule. Do not double-dose to compensate. The steady-state effect of tirzepatide means a single missed injection will not reverse weeks of progress, though consistency supports optimal weight loss and metabolic outcomes.

Can I stay on the starting dose of tirzepatide, or must I escalate to the higher doses?

Some patients see significant weight loss and metabolic benefit at lower doses (2.5–5 mg), while others require higher doses to achieve their goals. PlexusDx offers personalized guidance based on your response; dose escalation is not mandatory if you experience good results and tolerability at your current level. Your provider will help determine the optimal maintenance dose for your individual needs.

Are compounded tirzepatide injections as safe and effective as brand-name Mounjaro?

Yes. Compounded tirzepatide from licensed 503A pharmacies contains the identical active molecule and is prepared under strict pharmaceutical standards. Clinical outcomes are equivalent to brand-name versions. The primary difference is cost—PlexusDx tirzepatide injections are $289/mo month-to-month, or from $249/mo on the 6-month plan, compared to hundreds more for brand-name Mounjaro, making treatment more accessible without compromising safety or efficacy.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways involving 49 peptides, including genetic variants in GIPR, FTO, and MC4R—all linked to the appetite-regulation and metabolic pathways involved in weight management. Knowing your genotype at rs1800437 (GIPR) gives you and your provider pathway-level context for the conversation rather than a prediction of how you'll respond. This test costs $298.

Related Reading

• Mounjaro Doses
• Hers Mounjaro
• Hims Mounjaro
• Mounjaro For Hypertension

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.